Other

Baxter Aktiengesellschaft

Heinz Meise Gmbh

Drk-blutspendedienst West Gemeinnützige Gesellschaft MIT Beschränkter Haftung

Edgar Scheel

Thomas Seelich

Yves A Delmotte

Guenther Schlag

Georg Habison

Hamza Mansour

Wolfgang Biering

Roland Reschke

Dirk Reinert

Dieter Dickhörner

The invention relates to a hemostatic sponge based on collagen and an activator or proactivator of blood coagulation homogeneously distributed therein, which is dried and contains a water content of at least 2%, preferably in the range of 2 to 25%, more preferred 10 to 20%, and a method for producing this sponge.

Hemostatic sponge based on collagen

The invention relates to a fibrin sponge comprising a residual moisture content of at least 3%, preferably of 3 to 35%, in particular 10 to 20%, and preferably containing a blood clotting activator or proactivator, a method of preparing this fibrin sponge as well as a kit for wound gluing which comprises the fibrin sponge and a component containing a blood clotting factor. The sponge according to the present invention is suitable for hemostasis, tissue adhesion and aiding wound healing.

Fibrin sponge

Growing community of inventors

Hagen, Germany

Edgar Scheel